| # | Title | Journal | Year | Citations |
|---|
| 1 | EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016 | European Urology | 2017 | 1,594 |
| 2 | EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013 | European Urology | 2013 | 1,053 |
| 3 | European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update | European Urology | 2019 | 936 |
| 4 | European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update | European Urology | 2015 | 804 |
| 5 | EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update | European Urology | 2011 | 652 |
| 6 | European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update | European Urology | 2018 | 627 |
| 7 | EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder | European Urology | 2008 | 592 |
| 8 | European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ) | European Urology | 2022 | 559 |
| 9 | European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update | European Urology | 2021 | 532 |
| 10 | A Review of Current Guidelines and Best Practice Recommendations for the Management of Nonmuscle Invasive Bladder Cancer by the International Bladder Cancer Group | Journal of Urology | 2011 | 247 |
| 11 | European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era | European Urology | 2020 | 239 |
| 12 | Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel | European Urology | 2016 | 215 |
| 13 | Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non–muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review | European Urology | 2017 | 205 |
| 14 | Female Gender and Carcinoma In Situ in the Prostatic Urethra Are Prognostic Factors for Recurrence, Progression, and Disease-Specific Mortality in T1G3 Bladder Cancer Patients Treated With Bacillus Calmette-Guérin | European Urology | 2012 | 199 |
| 15 | European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel | European Urology | 2021 | 198 |
| 16 | Urine Markers for Detection and Surveillance of Non–Muscle-Invasive Bladder Cancer | European Urology | 2011 | 176 |
| 17 | Serum bone alkaline phosphatase levels enhance the clinical utility of prostate specific antigen in the staging of newly diagnosed prostate cancer patients | European Journal of Nuclear Medicine and Molecular Imaging | 1999 | 139 |
| 18 | EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort† | European Urology | 2020 | 132 |
| 19 | Development of a standardised training curriculum for robotic surgery: a consensus statement from an international multidisciplinary group of experts | BJU International | 2015 | 123 |
| 20 | MULTIVARIATE ANALYSIS OF CLINICAL PARAMETERS OF SYNCHRONOUS PRIMARY SUPERFICIAL BLADDER CANCER AND UPPER URINARY TRACT TUMOR | Journal of Urology | 2005 | 121 |
| 21 | Grading of Urothelial Carcinoma and The New “World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016” | European Urology Focus | 2019 | 112 |
| 22 | BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCG | Nature Reviews Urology | 2017 | 108 |
| 23 | Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review | European Urology Focus | 2019 | 103 |
| 24 | Mortality and flexible ureteroscopy: analysis of six cases | World Journal of Urology | 2016 | 101 |
| 25 | Defining Progression in Nonmuscle Invasive Bladder Cancer: It is Time for a New, Standard Definition | Journal of Urology | 2014 | 98 |
| 26 | EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees | Annals of Oncology | 2019 | 96 |
| 27 | An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer | World Journal of Urology | 2018 | 95 |
| 28 | Three-dimensional vs Standard Laparoscopy: Comparative Assessment Using a Validated Program for Laparoscopic Urologic Skills | Urology | 2013 | 90 |
| 29 | Clinical Practice Recommendations for the Prevention and Management of Intravesical Therapy–Associated Adverse Events | European Urology Supplements | 2008 | 87 |
| 30 | Current clinical practice gaps in the treatment of intermediate‐ and high‐risk non‐muscle‐invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette‐Guérin (BCG): results of an international individual patient data survey (IPDS) | BJU International | 2013 | 87 |
| 31 | European Association of Urology Guidelines on Renal Transplantation: Update 2018 | European Urology Focus | 2018 | 85 |
| 32 | Defining and Treating the Spectrum of Intermediate Risk Nonmuscle Invasive Bladder Cancer | Journal of Urology | 2014 | 82 |
| 33 | An International Collaborative Consensus Statement on En Bloc Resection of Bladder Tumour Incorporating Two Systematic Reviews, a Two-round Delphi Survey, and a Consensus Meeting | European Urology | 2020 | 77 |
| 34 | Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non–muscle-invasive Bladder Cancer | European Urology Focus | 2019 | 74 |
| 35 | Risk Stratification Tools and Prognostic Models in Non–muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel | European Urology Focus | 2020 | 72 |
| 36 | Transurethral Resection of the Intramural Ureter as the First Step of Nephroureterectomy | Journal of Urology | 1995 | 68 |
| 37 | Treatment Options Available for Bacillus Calmette-Guérin Failure in Non–muscle-invasive Bladder Cancer | European Urology | 2012 | 67 |
| 38 | Therapeutic Options in High-risk Non–muscle-invasive Bladder Cancer During the Current Worldwide Shortage of Bacille Calmette-Guérin | European Urology | 2015 | 62 |
| 39 | Best practices in near-infrared fluorescence imaging with indocyanine green (NIRF/ICG)-guided robotic urologic surgery: a systematic review-based expert consensus | World Journal of Urology | 2020 | 58 |
| 40 | Current status of urology surgical training in Europe: an ESRU–ESU–ESUT collaborative study | World Journal of Urology | 2020 | 56 |
| 41 | Metabolic syndrome increases the risk of aggressive prostate cancer detection | BJU International | 2013 | 54 |
| 42 | Learning Curve in Robot-assisted Kidney Transplantation: Results from the European Robotic Urological Society Working Group | European Urology | 2020 | 54 |
| 43 | Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population | World Journal of Urology | 2015 | 51 |
| 44 | Antiproliferative and apoptotic effects of the herbal agent Pygeum africanum on cultured prostate stromal cells from patients with benign prostatic hyperplasia (BPH) | Prostate | 2010 | 49 |
| 45 | The Metabolic Syndrome and its Components in Patients with Prostate Cancer on Androgen Deprivation Therapy | Journal of Urology | 2015 | 49 |
| 46 | Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non–Muscle-Invasive Bladder Cancer | Cancer Research | 2020 | 49 |
| 47 | Clinical utility of genetic testing in early-onset kidney disease: seven genes are the main players | Nephrology Dialysis Transplantation | 2022 | 44 |
| 48 | Outcomes after rectosigmoid resection for endometriosis: a systematic literature review | International Journal of Colorectal Disease | 2018 | 43 |
| 49 | Diagnostic accuracy of ureteroscopic biopsy in predicting stage and grade at final pathology in upper tract urothelial carcinoma: Systematic review and meta-analysis | European Journal of Surgical Oncology | 2020 | 43 |
| 50 | The use of mannitol in partial and live donor nephrectomy: an international survey | World Journal of Urology | 2013 | 42 |
